Versameb

OverviewSuggest Edit

Versameb is a biopharmaceutical company focusing on the discovery and development of innovative, next-generation RNA-based drugs. Its platform enables the efficient development of functional mRNA molecules for customized protein expression and modification in various therapeutic indications.

TypePrivate
Founded2017
HQBasel, CH
Websiteversameb.com

Latest Updates

Employees (est.) (Feb 2021)17
Cybersecurity ratingAMore

Key People/Management at Versameb

Isabel Ferreira

Isabel Ferreira

Chief Business Officer
Friedrich Metzger

Friedrich Metzger

Chief Scientific Officer & Co-Founder
Urs Breitenstein

Urs Breitenstein

Chief Finance Officer
Klaas Zuideveld

Klaas Zuideveld

Chief Executive Officer
Reinhard Ambros

Reinhard Ambros

Chairman of the Board
Show more

Versameb Office Locations

Versameb has an office in Basel
Basel, CH (HQ)
Hochbergerstrasse 60C
Show all (1)

Versameb Financials and Metrics

Summary Metrics

Founding Date

2017

Versameb total Funding

$18.2 m

Versameb latest funding size

$6.37 m

Time since last funding

7 months ago

Versameb investors

Versameb's latest funding round in July 2020 was reported to be $6.4 m. In total, Versameb has raised $18.2 m
Show all financial metrics

Versameb Cybersecurity Score

Cybersecurity ratingPremium dataset

A

95/100

SecurityScorecard logo

Versameb Online and Social Media Presence

Embed Graph

Versameb News and Updates

Versameb Announces Management Update

BASEL, Switzerland, Jan. 8, 2021 /PRNewswire/ -- Versameb AG ("Versameb"), a pre-clinical stage company focused on discovering and developing innovative RNA-based drugs, announces the appointment of Dr Klaas Zuideveld as Chief Executive Officer (CEO). Prof Friedrich Metzger will move back...

Versameb Raises CHF 6 Million and Strengthens Team to Advance its VERSagile Technology Platform Towards Clinical Trials

BASEL, Switzerland, July 15, 2020 /PRNewswire/ -- Versameb AG, a biopharmaceutical company developing innovative ribonucleic acid (RNA) therapeutics, announced today the closing of a CHF 6 million seed financing round. Versameb further strengthens its team by the appointment of Dr. Klaas...

Versameb Frequently Asked Questions

  • When was Versameb founded?

    Versameb was founded in 2017.

  • Who are Versameb key executives?

    Versameb's key executives are Isabel Ferreira, Friedrich Metzger and Urs Breitenstein.

  • How many employees does Versameb have?

    Versameb has 17 employees.

  • Who are Versameb competitors?

    Competitors of Versameb include Apotex Pharmachem, Scynexis and Solasia Pharma.

  • Where is Versameb headquarters?

    Versameb headquarters is located at Hochbergerstrasse 60C, Basel.

  • Where are Versameb offices?

    Versameb has an office in Basel.

  • How many offices does Versameb have?

    Versameb has 1 office.